Sinopharm Group Co. Ltd. (HKG:1099)
18.30
+0.26 (1.44%)
Apr 1, 2025, 4:08 PM HKT
Sinopharm Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Net Income | 7,050 | 9,054 | 8,526 | 7,759 | 7,187 | Upgrade
|
Depreciation & Amortization | 4,734 | 4,244 | 4,002 | 3,783 | 3,470 | Upgrade
|
Other Amortization | - | 166.75 | 147.53 | 126.74 | 203.36 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -492.31 | -3.11 | -65.87 | -152.96 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 80.36 | 95.7 | 648.22 | 272.62 | Upgrade
|
Loss (Gain) From Sale of Investments | - | 2,637 | 5,159 | 930.13 | 1,121 | Upgrade
|
Loss (Gain) on Equity Investments | - | -1,107 | -1,067 | -1,070 | -987.46 | Upgrade
|
Stock-Based Compensation | - | - | - | - | -18.57 | Upgrade
|
Provision & Write-off of Bad Debts | - | 614.54 | 431.88 | 445.77 | 669.84 | Upgrade
|
Other Operating Activities | -237.37 | 5,841 | 5,746 | 8,841 | 8,109 | Upgrade
|
Change in Accounts Receivable | - | -14,850 | 710.12 | -26,717 | -22,631 | Upgrade
|
Change in Inventory | - | 455.56 | -9,504 | -4,345 | -3,675 | Upgrade
|
Change in Accounts Payable | - | 10,784 | 8,315 | 19,805 | 11,664 | Upgrade
|
Change in Unearned Revenue | - | -3,961 | 4,314 | -1,265 | 2,152 | Upgrade
|
Change in Other Net Operating Assets | - | 3,706 | -5,909 | 421.26 | 3,770 | Upgrade
|
Operating Cash Flow | 11,546 | 17,173 | 20,964 | 9,308 | 11,155 | Upgrade
|
Operating Cash Flow Growth | -32.77% | -18.08% | 125.22% | -16.55% | -40.59% | Upgrade
|
Capital Expenditures | -2,461 | -1,960 | -2,127 | -2,074 | -1,897 | Upgrade
|
Sale of Property, Plant & Equipment | - | 456.13 | 172.34 | 134.01 | 173.5 | Upgrade
|
Cash Acquisitions | - | -108.24 | -449.15 | -497.22 | -2,567 | Upgrade
|
Divestitures | - | 26.44 | 81.18 | 6.12 | 100.3 | Upgrade
|
Sale (Purchase) of Intangibles | - | -324.01 | -188.75 | -153.06 | -157.91 | Upgrade
|
Investment in Securities | - | 102.59 | -51.17 | -8.15 | 23.16 | Upgrade
|
Other Investing Activities | -1,290 | 833.32 | -1,028 | 1,324 | 2,116 | Upgrade
|
Investing Cash Flow | -3,751 | -944.54 | -3,590 | -1,267 | -2,203 | Upgrade
|
Long-Term Debt Issued | - | 106,438 | 106,451 | 99,922 | 104,870 | Upgrade
|
Total Debt Issued | - | 106,438 | 106,451 | 99,922 | 104,870 | Upgrade
|
Long-Term Debt Repaid | - | -106,052 | -103,530 | -106,464 | -98,434 | Upgrade
|
Total Debt Repaid | - | -106,052 | -103,530 | -106,464 | -98,434 | Upgrade
|
Net Debt Issued (Repaid) | - | 385.68 | 2,921 | -6,543 | 6,437 | Upgrade
|
Issuance of Common Stock | - | - | - | - | 3,600 | Upgrade
|
Common Dividends Paid | - | -2,559 | -2,340 | -2,153 | -1,865 | Upgrade
|
Other Financing Activities | -17,285 | -5,471 | -6,274 | -5,997 | -6,146 | Upgrade
|
Financing Cash Flow | -17,285 | -7,644 | -5,693 | -14,693 | 2,026 | Upgrade
|
Foreign Exchange Rate Adjustments | -5.24 | 2.39 | 11.51 | 3.05 | 8.59 | Upgrade
|
Net Cash Flow | -9,495 | 8,587 | 11,692 | -6,649 | 10,986 | Upgrade
|
Free Cash Flow | 9,085 | 15,213 | 18,837 | 7,234 | 9,257 | Upgrade
|
Free Cash Flow Growth | -40.28% | -19.23% | 160.38% | -21.85% | -44.14% | Upgrade
|
Free Cash Flow Margin | 1.55% | 2.55% | 3.41% | 1.39% | 2.03% | Upgrade
|
Free Cash Flow Per Share | 2.92 | 4.88 | 6.04 | 2.32 | 2.98 | Upgrade
|
Cash Interest Paid | - | 3,199 | 4,778 | 4,575 | 4,644 | Upgrade
|
Cash Income Tax Paid | - | 4,575 | 4,399 | 4,074 | 3,655 | Upgrade
|
Levered Free Cash Flow | -10,809 | 10,158 | 15,174 | -2,358 | -1,893 | Upgrade
|
Unlevered Free Cash Flow | -9,106 | 12,000 | 17,368 | -17.52 | 240.33 | Upgrade
|
Change in Net Working Capital | 22,516 | 4,077 | -1,307 | 14,815 | 13,298 | Upgrade
|
Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.